Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
ASTRO 2025
Stereotactic Radiotherapy Boost in Locally Advanced Cervical Carcinoma Patients (STARBACS): Up-to-Date Results of a Phase II, Single Arm, Monoinstitutional Study
ASTRO 2025
Evaluation of Necessary and Sufficient PTV Margins for Offline Adaptive Head and Neck Cases Treated with TomoTherapy
ASTRO 2025
Stereotactic Body Radiation Therapy to Only Prostate and Proximal Seminal Vesicles is a Viable Option for a Favorable Subset of High-Risk Prostate Cancer Patients
Featured Case Studies
Robotic Stereotactic Body Radiation Therapy For High-risk Prostate Cancer: The Georgetown University Experience
This retrospective study examines cancer control and health-related quality of life (HRQOL) outcomes in high-risk prostate cancer patients receiving robotic stereotactic body radiation therapy (SBRT) with Synchrony® real-time adaptive motion management.
Use of Motion Management to Model Unmanaged Motion: Dosimetric Consequences of Unmanaged Prostate Motion Assessed Using Real-time Radiotherapy Adaptation Data
This case report explores the dosimetric impact of unmanaged intrafraction prostate motion during radiotherapy by retrospectively analyzing real-time motion data collected using the Radixact® System with Synchrony®. The study models what would have happened if a patient had been treated without motion management, using deformation vector fields to simulate dose
Stereotactic Body Radiotherapy of a Lung Tumor with Large Respiratory Motion Using Real-time Adaptive Motion Management: A Case Report
Traditional internal target volume (ITV) methods for the treatment of a lung tumor on conventional linac would require a large planning target volume (PTV), risking high radiation exposure to the chest wall and lungs.
3492: CyberKnife UH-SBRT for Localized Prostate Cancer and DIL: Preliminary Report of Acute and Late Toxicity of the PRO-SPEED Trial (NCT06331013)
Giovanni Carlo Mazzola et al. | ESTRO | 2025
3039: A Single Institution Study of Efficacy and Toxicity Outcomes of Spinal SBRT in Prostate Cancer
Binnaz Yasar et al. | ESTRO | 2025
1653: Early Results from a Trial on Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence After Prostatectomy: STARR (NCT05455736)
Niccolo’ Bertini et al. | ESTRO | 2025
1651: Stereotactic Body Radiotherapy for Localized Kidney Cancer Compared with Standard Surgery Within a Young Academic Urologists Working Group Database
Michele Aquilano et al. | ESTRO | 2025
1021: RE-START: A National Registry Including Patients Undergoing Reirradiation After Previous RT for Prostate Cancer. A Study on Behalf of AIRO
Giulio Francolini et al. | ESTRO | 2025
2454: Robotic Stereotactic Body Radiotherapy for Malignant Liver Lesions: Local Control and Overall Survival – a Mono Institutional Study
Mariam Zurabashvili et al. | ESTRO | 2025
540: Liver SBRT in More Than 4 Fractions: Local Control and Recurrence Patterns
Alizée Renan et al. | ESTRO | 2025
3765: Re-irradiation Experience: Is it Underused in XXI Century?
Escarlata López et al. | ESTRO | 2025
3732: Use of Stereotactic Body Radiotherapy (SBRT) for Spine Metastases with Robotic Radiosurgery Unit CyberKnife in Patients with Oligometastatic Disease
Adrián Durango Méndez et al. | ESTRO | 2025
3389: Analysis of Local Control and Pain Relief of Rib Metastases Treated with Stereotactic Body Radiotherapy
Chiara Mattioli et al. | ESTRO | 2025
2718: Gastro-intestinal Toxicity: NTCP Models Based on CT-guided Online Adaptive SBRT for Abdominal Lymph Node Oligometastases
Lucy A van Werkhoven et al. | ESTRO | 2025
2332: Increased Iso-toxic Dose to the Target in Oligometastatic Abdominal Lymph Nodes Using CT-guided Online Adaptive SBRT
Lucy A. van Werkhoven et al. | ESTRO | 2025
1417: A Review of 130 CyberKnife Spinal Metastasis SABR Treatments at One Centre to Assess Risk of Spinal Cord Toxicity
Timothy Jackson et al. | ESTRO | 2025
